Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("WILLIAMS, John P")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 38

  • Page / 2
Export

Selection :

  • and

Unsuccessful placement of transesophageal echocardiography probe because of esophageal pathologyPAISTE, Juhan; WILLIAMS, John P.Anesthesia and analgesia. 2001, Vol 92, Num 4, pp 870-871, issn 0003-2999Article

2-Amino-N-pyrimidin-4-ylacetamides as A2A Receptor Antagonists: 1. Structure-Activity Relationships and Optimization of Heterocyclic SubstituentsSLEE, Deborah H; YONGSHENG CHEN; MALANY, Siobhan et al.Journal of medicinal chemistry (Print). 2008, Vol 51, Num 6, pp 1719-1729, issn 0022-2623, 11 p.Article

Diplopia: A complication of dural punctureNISHIO, Isuta; WILLIAMS, Brian A; WILLIAMS, John P et al.Anesthesiology (Philadelphia). 2004, Vol 100, Num 1, pp 158-164, issn 0003-3022, 7 p.Article

A New Animal Model of Trigeminal Neuralgia Produced by Administration of Cobra Venom to the Infraorbital Nerve in the RatAN, Jian-Xiong; YING HE; QIAN, Xiao-Yan et al.Anesthesia and analgesia. 2011, Vol 113, Num 3, pp 652-656, issn 0003-2999, 5 p.Article

Selection, synthesis, and structure-activity relationship of tetrahydropyrido [4,3 -d]pyrimidine -2,4 -diones as human GnRH receptor antagonistsLANIER, Marion C; FEHER, Miklos; ASHWEEK, Neil J et al.Bioorganic & medicinal chemistry. 2007, Vol 15, Num 16, pp 5590-5603, issn 0968-0896, 14 p.Article

Effects of cyclosporine on osteoclast activity: Inhibition of calcineurin activity with minimal effects on bone resorption and acid transport activityWILLIAMS, John P; MCKENNA, Margaret A; THAMES, Allyn M et al.Journal of bone and mineral research (Print). 2003, Vol 18, Num 3, pp 451-457, issn 0884-0431, 7 p.Article

Effect of energy restriction and exercise on vitamin B-6 status of women during lactationLOVELADY, Cheryl A; WILLIAMS, John P; GARNER, Kimberly E et al.Medicine and science in sports and exercise. 2001, Vol 33, Num 4, pp 512-518, issn 0195-9131Article

Minimally invasive direct coronary artery bypass surgery under high thoracic epiduralPAISTE, Juhan; BJERKE, Richard J; WILLIAMS, John P et al.Anesthesia and analgesia. 2001, Vol 93, Num 6, pp 1486-1488, issn 0003-2999Article

Discovery of NBI-77860/GSKS61679, a potent corticotropin-releasing factor (CRF1) receptor antagonist with improved pharmacokinetic propertiesTELLEW, John E; LANIER, Marion; DI FABIO, Romano et al.Bioorganic & medicinal chemistry letters (Print). 2010, Vol 20, Num 24, pp 7259-7264, issn 0960-894X, 6 p.Article

2,6-Diaryl-4-phenacylaminopyrimidines as potent and selective adenosine A2A antagonists with reduced hERG liabilityMOORJANI, Manisha; XIAOHU ZHANG; MALANY, Siobhan et al.Bioorganic & medicinal chemistry letters (Print). 2008, Vol 18, Num 4, pp 1269-1273, issn 0960-894X, 5 p.Article

Synthesis of (3,4-dimethoxyphenoxy)alkylamino acetamides as orexin-2 receptor antagonistsCOLE, Andrew G; STROKE, Iiana L; SAUNDERS, John et al.Bioorganic & medicinal chemistry letters (Print). 2008, Vol 18, Num 20, pp 5420-5423, issn 0960-894X, 4 p.Article

Human peripheral blood mononuclear cells express nociceptin/orphanin FQ, but not μ, 6, or κ opioid receptorsWILLIAMS, John P; THOMPSON, Jonathan P; MCDONALD, John et al.Anesthesia and analgesia. 2007, Vol 105, Num 4, pp 998-1005, issn 0003-2999, 8 p.Article

Design and synthesis of tricyclic corticotropin-releasing factor-1 antagonistsGROSS, Raymond S; ZHIQIANG GUO; GRIGORIADIS, Dimitri E et al.Journal of medicinal chemistry (Print). 2005, Vol 48, Num 18, pp 5780-5793, issn 0022-2623, 14 p.Article

Administration of PTH-(7-84) antagonizes the effects of PTH-(1-84) on bone in rats with moderate renal failureLANGUB, M. Chris; MONIER-FAUGERE, Marie-Claude; GUODONG WANG et al.Endocrinology (Philadelphia). 2003, Vol 144, Num 4, pp 1135-1138, issn 0013-7227, 4 p.Article

Identification of Novel, Water-Soluble, 2-Amino-N-pyrimidin-4-yl Acetamides as A2A Receptor Antagonists with In Vivo EfficacySLEE, Deborah H; XIAOHU ZHANG; JOSWIG, Tanya et al.Journal of medicinal chemistry (Print). 2008, Vol 51, Num 3, pp 400-406, issn 0022-2623, 7 p.Article

Synthesis of N-pyrimidinyl-2-phenoxyacetamides as adenosine A2A receptor antagonistsXIAOHU ZHANG; RUETER, Jaimie K; MARKISON, Stacy et al.Bioorganic & medicinal chemistry letters (Print). 2008, Vol 18, Num 6, pp 1778-1783, issn 0960-894X, 6 p.Article

Lead Optimization of 4-Acetylamino-2-(3,5-dimethylpyrazol-1-yl)-6-pyridylpyrimidines as A2A Adenosine Receptor Antagonists for the Treatment of Parkinson's DiseaseXIAOHU ZHANG; TELLEW, John E; MARKISON, Stacy et al.Journal of medicinal chemistry (Print). 2008, Vol 51, Num 22, pp 7099-7110, issn 0022-2623, 12 p.Article

Hippocampal T2 signal change during amygdala kindling epileptogenesisJUPP, Bianca; WILLIAMS, John P; TESIRAM, Yasvir A et al.Epilepsia (Copenhagen). 2006, Vol 47, Num 1, pp 41-46, issn 0013-9580, 6 p.Article

PACU bypass after outpatient knee surgery is associated with fewer unplanned hospital admissions but more phase II nursing interventionsWILLIAMS, Brian A; KENTOR, Michael L; WILLIAMS, John P et al.Anesthesiology (Philadelphia). 2002, Vol 97, Num 4, pp 981-988, issn 0003-3022, 8 p.Article

Calmodulin and HIV type 1: Interactions with Gag and Gag productsRADDING, Wilson; WILLIAMS, John P; MCKENNA, Margaret A et al.AIDS research and human retroviruses. 2000, Vol 16, Num 15, pp 1519-1525, issn 0889-2229Article

Forum on Aging and Skeletal Health: Summary of the Proceedings of an ASBMR WorkshopKHOSLA, Sundeep; BELLIDO, Teresita M; ROSEN, Clifford J et al.Journal of bone and mineral research (Print). 2011, Vol 26, Num 11, pp 2565-2578, issn 0884-0431, 14 p.Article

N-[6-Amino-2-(heteroaryl)pyrimidin-4-yl]acetamides as A2AReceptor Antagonists with Improved Drug Like Properties and in Vivo EfficacyLANIER, Marion C; MOORJANI, Manisha; MARKISON, Stacy et al.Journal of medicinal chemistry (Print). 2009, Vol 52, Num 3, pp 709-717, issn 0022-2623, 9 p.Article

2-Amino-N-pyrimidin-4-ylacetamides as A2A Receptor Antagonists: 2. Reduction of hERG Activity, Observed Species Selectivity, and Structure-Activity RelationshipsSLEE, Deborah H; MOORJANI, Manisha; JOSWIG, Tanya et al.Journal of medicinal chemistry (Print). 2008, Vol 51, Num 6, pp 1730-1739, issn 0022-2623, 10 p.Article

2,6-Diaryl-4-acylaminopyrimidines as potent and selective adenosine A2A antagonists with improved solubility and metabolic stabilityMOORJANI, Manisha; ZHIYONG LUO; WILLIAMS, John P et al.Bioorganic & medicinal chemistry letters (Print). 2008, Vol 18, Num 20, pp 5402-5405, issn 0960-894X, 4 p.Article

Design and synthesis of tricyclic imidazo[4,5-b]pyridin-2-ones as corticotropin-releasing factor-1 antagonistsZHIQIANG GUO; TELLEW, John E; MCCARTHY, James R et al.Journal of medicinal chemistry (Print). 2005, Vol 48, Num 16, pp 5104-5107, issn 0022-2623, 4 p.Article

  • Page / 2